🇺🇸 FDA
Patent

US 10227290

Glycosphingolipids for use in modulating immune responses

granted A61KA61K2035/122A61K35/26

Quick answer

US patent 10227290 (Glycosphingolipids for use in modulating immune responses) held by The Regents of the University of California expires Mon Mar 07 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Mar 12 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 07 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
12
CPC classes
A61K, A61K2035/122, A61K35/26, A61P, A61P31/04